IBRN vs. THNR ETF Comparison
Comparison of iShares Neuroscience and Healthcare ETF (IBRN) to Amplify Weight Loss Drug & Treatment ETF (THNR)
IBRN
iShares Neuroscience and Healthcare ETF
IBRN Description
iShares Neuroscience and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of global region. It invests in stocks of companies operating across neurology biopharmaceuticals or neurological devices sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE FactSet Global Neuro Biopharma and MedTech Index, by using representative sampling technique. iShares Neuroscience and Healthcare ETF is domiciled in the United States.
Grade (RS Rating)
Last Trade
$26.17
Average Daily Volume
360
9
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.Grade (RS Rating)
Last Trade
$23.15
Average Daily Volume
2,584
15
Performance
| Period | IBRN | THNR |
|---|---|---|
| 30 Days | -3.79% | -11.31% |
| 60 Days | 2.72% | -15.54% |
| 90 Days | 0.03% | -17.09% |
| 12 Months | 25.03% |
0 Overlapping Holdings
| Symbol | Grade | Weight in IBRN | Weight in THNR | Overlap |
|---|
IBRN: Top Represented Industries & Keywords
THNR: Top Represented Industries & Keywords
Compare ETFs
